中国卒中杂志 ›› 2020, Vol. 15 ›› Issue (12): 1342-1351.DOI: 10.3969/j.issn.1673-5765.2020.12.015
周立新,倪俊
收稿日期:
2020-07-01
出版日期:
2020-12-20
发布日期:
2020-12-20
通讯作者:
倪俊 pumchnijun@163.com
基金资助:
“十三五”国家重点研发计划慢病专项(2016YFC1300500-5)
Received:
2020-07-01
Online:
2020-12-20
Published:
2020-12-20
摘要:
穿支动脉粥样硬化性疾病(branch atheromatous disease,BAD)是引起急性孤立性皮层下梗 死的常见且重要的病因,尤以亚洲人群多见。与脑小血管病所致腔隙性梗死比较,BAD相关梗死灶直 径、形态学分布具有一定的特征性。BAD相关卒中急性期更易出现症状波动或神经功能恶化,早期预 后不良。目前BAD仍缺乏统一的临床影像诊断标准,使得BAD临床研究及精准诊疗面临挑战。近期应 用高分辨及高场强磁共振技术可同时显示载体动脉管壁和穿支动脉形态,未来有望突破BAD的发病 机制研究的瓶颈。本文对BAD临床影像特征、诊断标准及防治策略等进行综述,以期提高临床医师 的重视和认知水平。
周立新,倪俊. 穿支动脉粥样硬化性疾病的诊治进展[J]. 中国卒中杂志, 2020, 15(12): 1342-1351.
ZHOU Li-Xin, NI Jun. Advances in Branch Atheromatous Disease[J]. Chinese Journal of Stroke, 2020, 15(12): 1342-1351.
[1] CAPLAN L R. Intracranial branch atheromatousdisease:a neglected,understudied,and underusedconcept[J]. Neurology,1989,39(9):1246-1250.[2] CHUNG J W,KIM B J,SOHR C H,et al. Branchatheromatous plaque:a major cause of lacunarinfarction(high-resolution MRI study)[J].Cerebrovasc Dis Extra,2012,2(1):36-44.[3] GAO S,WANG Y J,XU A D,et al. Chineseischemic stroke subclassification[J/OL]. Front Neurol,2011,2:6[2020-06-20]. https://doi.org/10.3389/fneur.2011.00006.[4] NAKASE T,YOSHIOKA S,SASAKI M,et al.Clinical evaluation of lacunar infarction and branchatheromatous disease[J]. J Stroke Cerebrovasc Dis,2013,22(4):406-412.[5] DEGUCHI I,HAYASHI T,KATO Y,et al.Treatment outcomes of tissue plasminogen activatorinfusion for branch atheromatous disease[J/OL]. J Stroke Cerebrovasc Dis,2013,22(7):e168-e172[2020-06-20]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.10.012.[6] PARK M G,OH E H,KIM B K,et al. Intravenoustissue plasminogen activator in acute branchatheromatous disease:does it prevent earlyneurological deterioration?[J/OL]. J Clin Neurosci,2016,33:194-197[2020-06-20]. https://doi.org/10.1016/j.jocn.2016.04.011.[7] FISHER C M. The vascular lesion in lacunae[J].Trans Am Neurol Assoc,1965,90:243-245.[8] FISHER C M,CAPLAN L R. Basilar arterybranch occlusion:a cause of pontine infarction[J].Neurology,1971,21(9):900-905.[9] FISHER C M. Bilateral occlusion of basilar arterybranches[J]. J Neurol Neurosurg Psychiatry,1977,40(12):1182-1189.[10] WONG K S,CAPLAN L R,KIM J S. Strokemechanisms[J/OL]. Front Neurol Neurosci,2016,40:58-71[2020-06-20]. https://doi.org/10.1159/000448302.[11] ADACHI T,KOBAYASHI S,YAMAGUCHI S,etal. MRI findings of small subcortical ‘lacunar-like’infarction resulting from large vessel disease[J]. JNeurol,2000,247(4):280-285.[12] BANG O Y,HEO J H,KIM J Y,et al. Middlecerebral artery stenosis is a major clinicaldeterminant in striatocapsular small,deepinfarction[J]. Arch Neurol,2002,59(2):259-263.[13] MOK V C,FAN Y H,LAM W W,et al. Smallsubcortical infarct and intracranial large arterydisease in Chinese[J]. J Neurol Sci,2003,216(1):55-59.[14] TATSUMI S,YAMAMOTO T. An autopsied case ofan apparent pontine branch atheromatous disease[J].Eur Neurol,2010,63(3):184-185.[15] KWAN M W,MAK W,CHEUNG R T,et al.Ischemic stroke related to intracranial branchatheromatous disease and comparison with largeand small artery diseases[J]. J Neurol Sci,2011,303(1/2):80-84.[16] YAMAMOTO Y,OHARA T,HAMANAKAM,et al. Characteristics of intracranial branchatheromatous disease and its association withprogressive motor deficits[J]. J Neurol Sci,2011,304(1/2):78-82.[17] LIU Y,FAN Y T,LIU Y M,et al. A retrospectivestudy of branch atheromatous disease:analyses ofrisk factors and prognosis [J]. J Huazhong Univ SciTechnolog Med Sci,2017,37(1):93-99.[18] KIM J S,LEE J H,IM J H,et al. Syndromes ofpontine base infarction. A clinical-radiologicalcorrelation study[J]. Stroke,1995,26(6):950-955.[19] CHUNG C P,YONG C S,CHANG F C,et al.Stroke etiology is associated with outcome inposterior circulation stroke[J]. Ann Clin TranslNeurol,2015,2(5):510-517.[20] YOON Y,LEE D H,KANG D W,et al. Strokerecurrence patterns are predicted by the subtypesand mechanisms of the past,non-cardiogenicstroke[J]. Eur J Neurol,2013,20(6):928-934.[21] MEN X J,LI J J,ZHANG B J,et al. Homocysteineand C-reactive protein associated with progressionand prognosis of intracranial branch atheromatousdisease[J/OL]. PLoS One,2013,8(9):e73030[2020-06-20]. https://doi.org/1371/journal.pone.0073030.[22] CAPLAN L R. Diabetes and brain ischemia[J/OL].Diabetes,1996,45(suppl 3):S95-S97[2020-06-20].https://doi.org/10.2337/diab.45.3.s95.[23] ZHOU L X,YAO M,PENG B,et al. Atherosclerosismight be responsible for branch artery disease:evidence from white matter hyperintensity burden inacute isolated pontine infarction[J/OL]. Front Neurol,2018,9:840[2020-06-20]. https://doi.org/10.3389/fneur.2018.00840.[24] SUN S Y,WANG Y Q,WANG Y G,et al. Lipidand hyperglycemia factors in first-ever penetratingartery infarction,a comparison between differentsubtypes[J/OL]. Brain Behav,2017,7(6):e00694[2020-06-20]. https://doi.org/10.1002/brb3.694.[25] DONAN G A,O’MALLEY H M,QUANG L,et al.The capsular warning syndrome[J]. Neurology,1993,43(5):957-962.[26] ZHOU L X,NI J,XU W H,et al. High-resolutionMRI findings in patients with capsular warningsyndrome[J/OL]. BMC Neurol,2014,14:16[2020-06-20]. https://doi.org/10.1186/1471-2377-14-16.[27] MATSUZONO K,SUZUKI M,FURUYAK,et al. Hemichorea-hemiballism by branchatheromatous disease with a unique cerebral bloodflow abnormality[J/OL]. J Neurol Sci,2018,393:113-115[2020-06-20]. https://doi.org/10.1016/j.jns.2018.08.021.[28] KIM D E,CHOI M J,KIM J T,et al. Two differentclinical entities of small vessel occlusion in TOASTclassification[J]. Clin Neurol Neurosurg,2013,115(9):1686-1692.[29] JEONG H G,KIM B J,YANG M H,et al.Neuroimaging markers for early neurologicdeterioration in single small subcortical infarction[J].Stroke,2015,46(3):687-691.[30] NAKASE T,YAMAMOTO Y,TAKAG M,etal. The impact of diagnosing branch atheromatousdisease for predicting prognosis[J]. J StrokeCerebrovasc Dis,2015,24(10):2423-2438.[31] DEL BENE A,PALUMBO V,LAMASSA M,et al.Progressive lacunar stroke:review of mechanisms,prognostic features,and putative treatments[J]. Int JStroke,2012,7(4):321-329.[32] SUTO Y,NAKAYASU H,MAEDA M,et al. Longtermprognosis of patients with large subcorticalinfarctions[J]. Eur Neurol,2009,62(5):304-310.[33] PETRONE L,NANNONI S,DEL BENE A,etal. Branch atheromatous disease:a clinicallymeaningful,yet unproven concept[J]. CerebrovascDis,2016,41(1/2):87-95.[34] FEEKES J A,HSU S W,CHALOUPKA J C,etal. Tertiary microvascular territories define lacunarinfarcts in the basal ganglia[J]. Ann Neurol,2005,58 (1):18-30.[35] PHAN T G,VAN DER VOORT S,BEARE R,et al.Dimensions of subcortical infarcts associated withfirst- to third-order branches of the basal gangliaarteries[J]. Cerebrovasc Dis,2013,35(3):262-267.[36] CAO Y Z,ZHANG M Y,ZHOU L X,etal. Consecutive slides on axial view is moreeffective than transversal diameter to differentiatemechanisms of single subcortical infarctions in thelenticulostriate artery territory[J/OL]. Front Neurol,2019,10:336[2020-06-20]. https://doi.org/10.3389/fneur.2019.00336.[37] NAH H W,KANG D W,KWON S U,et al.Diversity of single small subcortical infarctionsaccording to infarct location and parent arterydisease:analysis of indicators for small vesseldisease and atherosclerosis[J]. Stroke,2010,41(12):2822-2827.[38] MEN X J,WU A M,ZHANG B J,et al.Leukoaraiosis and NIHSS score help to differentiatesubtypes of intracranial branch atheromatous diseasein Southern Han Chinese patients with stroke[J]Neurol Sci,2013,34(10):1727-1733.[39] MIYAJI Y,KAWABATA Y,JOKI H,et al. Highresolutionmagnetic resonance imaging findingsof basilar artery plaque in a patient with branchatheromatous disease:a case report[J/OL]. J MedCase Rep,2014,8:395[2020-06-20]. https://doi.org/10.1186/1752-1947-8-395.[40] RYOO S,LEE M J,CHA J,et al. Differentialvascular pathophysiologic types of intracranialatherosclerotic stroke:a high-resolution wallmagnetic resonance imaging study[J]. Stroke,2015,46(10):2815-2821.[41] ZHANG Z H,FAN Z Y,KONG Q L,et al.Visualization of the lenticulostriate arteries at 3Tusing black-blood T1-weighted intracranial vesselwall imaging:comparison with 7T TOF-MRA[J].Eur Radiol,2019,29(3):1452-1459.[42] JIANG S,YAN Y Y,YANG T,et al. Plaquedistribution correlates with morphology oflenticulostriate arteries in single subcorticalinfarctions[J]. Stroke,2020,51(9):2801-2809.[43] RUTLAND J W,DELMAN B N,GILL C M,et al.Emerging use of ultra-high-field 7T MRI in the studyof intracranial vascularity:state of the field andfuture directions[J]. AJNR Am J Neuroradiol,2020,41(1):2-9.[44] MURAYAMA K,SUZUKI S,NAGATA H,etal. Visualization of lenticulostriate arteries onCT angiography using ultra-high-resolution CTcompared with conventional-detector CT[J]. AJNRAm J Neuroradiol,2020,41(2):219-223.[45] ADAMS H P,BENDIXEN B H,KAPPELLE L J,etal. Classification of subtype of acute ischemic stroke.Definitions for use in a multicenter clinical trial[J].Stroke,1993,24(1):35-41.[46] HART R G,DEINER H C,COUTTS S B,et al.Embolic strokes of undetermined source:the case fora new clinical construct[J]. Lancet Neurol,2014,13(4):429-438.[47] UCHIYAMA S,TOYODA K,KITAGAWA K,et al.Branch atheromatous disease diagnosed as embolicstroke of undetermined source:a sub-analysis ofNAVIGATE ESUS[J]. Int J Stroke,2019,14(9):915-922.[48] MUSTANOJA S,MERETOJA A,PUTAALA J,etal. Outcome by stroke etiology in patients receivingthrombolytic treatment:descriptive subtypeanalysis[J]. Stroke,2011,42(1):102-106.[49] YAMAMOTO Y,NAGAKANE Y,MAKINO M,et al. Aggressive antiplatelet treatment for acutebranch atheromatous disease type infarcts:a 12-yearprospective study[J/OL]. Int J Stroke,2014,9(3):E8[2020-06-20]. https://doi.org/10.1111/ijs.12200.[50] KIMURA T,TUCKER A,SUGIMURA T,et al.Ultra-early combination antiplatelet therapy withcilostazol for the prevention of branch atheromatousdisease:a multicenter prospective study[J].Cerebrovasc Dis Extra,2016,6(3):84-95.[51] LI W,WU Y,LI X S,et al. Intravenous tirofibantherapy for patients with capsular warningsyndrome[J]. Stroke Vasc Neurol,2019,4(1):22-27.[52] PHILIPPS J,THOMALLA G,GLAHN J,et al.Treatment of progressive stroke with tirofiban--experience in 35 patients[J]. Cerebrovasc Dis,2009,28(5):435-438.[53] YAMAMOTA Y,OHARA T,ISHII R,et al. Acombined treatment for acute larger lacunar-typeinfarction [J]. J Stroke Cerebrovasc Dis,2011,20(5):387-394. |
[1] | 郑占军, 赵性泉. 脑小血管病影像学标志物与自发性高血压脑出血的相关性研究进展[J]. 中国卒中杂志, 2022, 17(12): 1396-1402. |
[2] | 陈超, 万慧娟, 董文玉, 王圣松, 余苹, 邵晓秋. 脑小血管病总负荷与中老年癫痫患者认知功能的相关性[J]. 中国卒中杂志, 2022, 17(06): 622-627. |
[3] | 马佳丽, 王玉青, 王恺闻, 东晶晶, 李永秋. 脑小血管病总负荷的影响因素探索及临床预测模型建立[J]. 中国卒中杂志, 2022, 17(05): 523-528. |
[4] | 叶益超, 玉石, 佘亚军, 方正, 王毅. 血管性帕金森综合征的研究进展[J]. 中国卒中杂志, 2022, 17(04): 346-350. |
[5] | 朱翠婷, 胡文立. 头晕/眩晕患者脑小血管病总负荷的危险因素分析[J]. 中国卒中杂志, 2022, 17(04): 354-359. |
[6] | 曹双双, 张晓燕, 王建伟, 赵磊, 陈红兵, 汪明玉. 急性缺血性卒中静脉溶栓后早期神经功能恶化影响因素分析[J]. 中国卒中杂志, 2021, 16(12): 1253-1258. |
[7] | 薛晶, 张广, 孙宏巍, 翟蕴, 孙艳艳, 汤颖. 以细菌性脑膜炎为病因的合并脑小血管病影像表现的颅内深静脉血栓形成1例[J]. 中国卒中杂志, 2021, 16(12): 1273-1277. |
[8] | 刘宏顺, 赵凤丽, 戴海琳, 樊帆, 刘丽萍, 米东华, 张长青, 郭力. 新发孤立脑干梗死患者1年预后的影响因素分析[J]. 中国卒中杂志, 2021, 16(10): 1039-1043. |
[9] | 杜万良. 穿支动脉闭塞性脑梗死亟待解决的问题[J]. 中国卒中杂志, 2021, 16(09): 873-875. |
[10] | 王一轻, 刘平国, 沈佳慧, 蔡增林. 脑穿支动脉病变梗死类型和神经影像学研究进展[J]. 中国卒中杂志, 2021, 16(09): 877-882. |
[11] | 刘慧琳, 刘东涛, 卜乔, 李坤, 潘振宇, 范小伟, 周立春. 脑小血管病相关轻度认知功能障碍患者边缘系统微结构改变研究[J]. 中国卒中杂志, 2021, 16(08): 793-798. |
[12] | 中国研究型医院学会脑小血管病专业委员会《中国脑小血管病诊治专家共识》编写组. 中国脑小血管病诊治专家共识2021[J]. 中国卒中杂志, 2021, 16(07): 716-726. |
[13] | 王伊龙. 《穿支动脉粥样硬化病中国专家共识》解读[J]. 中国卒中杂志, 2021, 16(07): 728-729. |
[14] | 秦伟,胡红梅,李譞婷,王韵,杨淑娜,胡文立. 青年缺血性卒中患者脑小血管病总负荷的危险因素分析[J]. 中国卒中杂志, 2021, 16(05): 470-474. |
[15] | 门雪娇,陈玮琪,许玉园,朱以诚,胡文立,程忻,柏峰,王丽华,毛玲,曲辉,吕佩源,刘军,孙中武,孙莉,李玉生,吴中亮,吴丹红,吴波,谷文萍,范玉华,周国钰. 穿支动脉粥样硬化病中国专家共识[J]. 中国卒中杂志, 2021, 16(05): 508-514. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||